Familial Mediterranean Fever (FMF): From diagnosis to treatment;La fièvre Méditerranéenne Familiale (FMF): Du diagnostic au traitement

Cahiers Sante

Volumn 14, Issue 4, 2004, Pages 261-266

  Medlej Hashim, Myrna ^a   Loiselet, Jacques ^a   Lefranc, Gérard ^b   Mégarbané, André ^a  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

^b CNRS and University Montpellier II   (France)

Author keywords

Familial Mediterranean Fever; Genetics; Hereditary disease

Indexed keywords

ALBUMIN; ALPHA 2 MACROGLOBULIN; AMYLOID A PROTEIN; ARACHIDONIC ACID; BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; COLCHICINE; COMPLEMENT COMPONENT C5A; FIBRINOGEN; GENOMIC DNA; HAPTOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE; LIPOPROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MARENOSTRIN; PHOSPHOLIPASE A2; PROTEIN; PROTEIN P55; PROTEIN P75; PYRIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ABDOMINAL PAIN; ACTIN FILAMENT; ALBUMIN BLOOD LEVEL; APOPTOSIS; ARTHRALGIA; ARTHRITIS; AUTOSOMAL RECESSIVE DISORDER; CHROMOSOME 16P; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFICACY; ERYSIPELAS; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; EXON; FAMILIAL MEDITERRANEAN FEVER; FEVER; FIBRINOGEN BLOOD LEVEL; GENE FREQUENCY; GENE IDENTIFICATION; GENOTYPE; HOMOZYGOTE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; KIDNEY AMYLOIDOSIS; LABORATORY TEST; LEUKOCYTE COUNT; LONG TERM CARE; MICROTUBULE; MUTATIONAL ANALYSIS; MYALGIA; NEUTROPHIL; PERITONEAL FLUID LEVEL; PHENOTYPE; PLEURISY; PROTEIN BLOOD LEVEL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RACE DIFFERENCE; REVIEW; RISK FACTOR; SEROSA; SYMPTOM; THORAX PAIN;

ADULT; AMYLOIDOSIS; ARABS; COLCHICINE; DIAGNOSIS, DIFFERENTIAL; ETHNIC GROUPS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENOTYPE; HOMOZYGOTE; HUMANS; IMMUNOGLOBULINS; JEWS; KIDNEY DISEASES; MALE; MUTATION; PHENOTYPE; POLYMORPHISM, GENETIC; TIME FACTORS;

EID: 15344341604     PISSN: 11575999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Méry JP, Dodé C, Grateau G. Les fièvres récurrentes héréditaires à l'ère de la biologie moléculaire. Médecine/Sciences 2001; 17: 1008-16.
2. Siegal S. Benign paroxysmal peritonitis. Ann Int Med 1945; 23: 1-21.
3. Reimann HA. Periodic disease: Probable syndrome including periodic fever, benign paroxysmal peritonitis, cyclic neutropenia, and intermittent arthralgia. JAMA 1948; 136: 239-44.
4. Mamou H, Cattan R. La Maladie périodique (sur 14 cas personnels dont 8 compliqués de néphropathies). Semaine hôp Paris 1952; 28: 1062.
5. Reimann HA, Moadié J, Semerdjian S, Sahyoun PF. Periodic peritonitis-Heredity and pathology. Report of seventy-two cases. JAMA 1954; 154: 1254-9.
6. Heller H, Sohar E, Sherf L. Familial Mediterranean Fever. Arch Int Med 1958; 102: 50-71.
7. Sohar E, Gafni J, Mordehai P, Heller H. Familial Mediterranean Fever. A survey of 470 cases and review of the literature. Am J Med 1967; 43: 227-53.
8. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40: 1879-85.
9. Khachadurian AK, Armenian HK. Familial paroxysmal polyserositis (familial Mediterranean fever); incidence of amyloidosis and mode of inheritance. Birth Defects 1974; 10: 62-4.
10. Rawashdeh MO, Majeed HA. Familial Mediterranean fever in Arab children: the high prevalence and gene frequency. Eur J Pediatr 1996; 155: 540-4.
11. Ozen S, Karaaslan Y, Ozdemir O, et al. Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol 1998; 25: 2445-9.
12. Yuval Y, Hemo-Zisser M, Sohar E, Pras M. Dominant inheritance in two families with familial Mediterranean fever (FMF). Am J Med Genet 1995; 57: 455-7.
13. Cazeneuve C, Dode C, Delpech M, Touitou I, Grateau G, Amselem S, Société Française de Génétique Humaine. Commission «Pratique de la Génétique». Fiche de synthèse des données scientifiques utiles au Conseil Génétique. Fièvre méditerranéenne familiale. Ann Genet 1999; 4: 241-5.
14. Livneh A, Drenth JPH, Klasen IS, et al. Familial Mediterranean fever and hyperimmunoglobulinemia D syndrome: two diseases with distinct clinical, sérologic, and genetic features. J Rheumatol 1997; 24: 1558-63.
15. Gang N, Drenth JPH, Langevitz P, et al. Activation of the cytokine network in familial Mediterranean fever. J Rheumatol 1999; 26: 890-7.
16. Matzner Y, Brzezinski A. C5a-inhibitor deficiency in peritoneal fluids from patients with familial Mediterranean fever. N Engl J Med 1984; 311: 287-90.
17. Notarnicola C, Didelot MN, Seguret F, Demaille J, Touitou I. Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean fever. Genes Immun 2002; 3: 43-5.
18. The French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997; 17: 25-31.
19. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997; 90: 797-807.
20. Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet 2001; 9: 473-83.
21. Mansour I, Delague V, Cazeneuve C, et al. Familial Mediterranean fever in Lebanon: mutation spectrum, evidence for cases in Maronites, Greek orthodoxes, Greek catholics, Syriacs and Chiites and for an association between amyloidosis and M694V and M694I mutations. Eur J Hum Genet 2001; 9: 51-5.
22. Medlej-Hashim M, Rawashdeh M, Chouery E, et al. Genetic screening of fourteen mutations in Jordanian familial Mediterranean fever patients. Hum Mutat 2000; 15: 384-90.
23. Tekin M, Yalçinkaya F, Cakar N, et al. MEFV mutations in multiplex families with familial Mediterranean fever: is a particular genotype necessary for amyloidosis? Clin Genet 2000; 57: 430-4.
24. Medlej-Hashim M, Petit I, Adib S, et al. Familial Mediterranean Fever: association of elevated IgD plasma levels with specific MEFV mutations. Eur J Hum Genet 2001; 9: 849-54.
25. Medlej-Hashim M, Salem N, Chouery E, et al. Familial Mediterranean fever: the potential for misdiagnosis of E148V using the E148Q usual RFLP detection method. Clin Genet 2002; 61: 71-3.
26. Kogan A, Shinar Y, Lidar M, et al. Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state. Am J Med Genet 2001; 102: 272-6.
27. Centola M, Wood G, Frucht DM, et al. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 2000; 95: 3223-31.
28. Mansfield E, Chae JJ, Komarow HD, et al. The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments. Blood 2001; 98: 851-9.
29. Richards N, Schaner P, Diaz A, et al. Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. J Biol Chem 2001; 276: 39320-9.
30. Goldfinger SE. Colchicine for familial Mediterranean fever. N Engl J Med 1972; 287: 1302.
31. Majeed HA, Carroll JE, Khuffash FA, Hijazi Z. Long-term colchicine prophylaxis in children with familial Mediterranean fever (recurrent hereditary polyserositis). J Pediatr 1990; 116: 997-9.
32. Tunca M, Tunkurt E, Akbaylar Akpinar H, Akar S, Hizli N, Gonen O. The efficacy of interferon alpha on colchicine-resistant familial Mediterraneen fever attacks: a pilot study. Br J Rheumatol 1997; 36: 1005-8.
33. Seyahi E, Ozdogan H, Masatlioglu S, Yazici H. Successful treatment of familial Mediterranean fever attacks with thalidomide in a colchicine resistant patient. Clin Exp Rheumatol 2002; 20: S43-S4.
34. Touitou I, Picot MC, Domingo C, et al. The MICA region determines the first modifier locus in familial Mediterranean fever. Arth Rheum 2001; 44: 163-9.
35. Medlej-Hashim M, Delague V, Chouery E, et al. Amyloidosis in familial Mediterranean fever patients: correlation with MEFV genotype and SAA1 and MICA polymorphisms effects. BMC Med Genet 2004; 5: 4.
36. Cazeneuve C, Ajrapetyan H, Papin S, et al. Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 2000; 67: 1136-43.
37. Hull KM, Shoham N, Chae JJ, Aksentijevich I, Kastner DL. The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr Opin Rheumatol 2003; 15: 61-9.
38. Touitou I, Magne X, Molinari N, et al. MEFV mutations in Behçet's disease. Hum Mutat 2000; 16: 271-2.